Merck is in deep negotiations to acquire cancer drug manufacturer HARPOON Therapeutics for approximately $700 million
我放心你带套猛
发表于 2024-1-8 14:01:17
281
0
0
Merck is in deep negotiations to acquire cancer drug manufacturer HARPOON Therapeutics for approximately $700 million.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- AstraZeneca acquires a Chinese cancer drug developer with a transaction value of approximately $1.2 billion
- TSMC's CoWoS Capacity Full Load AMD Seeks Cooperation with Other CoWoS Packaging Capability Manufacturers
- Amazon abandons $1.4 billion acquisition of sweeping robot manufacturer iRobot and plans to lay off 31% of employees
- Olio manufacturer fined over 2.6 billion yuan for violating EU antitrust laws
- Aircraft manufacturers using counterfeit titanium components? Boeing and Airbus response: After analysis, the in-service fleet has not been affected
- Merck's small molecule cancer drug, acquired for over $1.3 billion, launches Phase 3 clinical trials in China
- Bristol Myers Squibb's original tumor treatment drug Abraxane has been officially launched in China
- US chip manufacturer Wolfspeed plans to receive $750 million in funding from the US Department of Commerce
- Google has reached a strategic partnership with domestic consumer grade AR glasses manufacturer XREAL
- The sharp drop in the early morning has caused multiple circuit breakers! Technology instrument manufacturer SOBR SAFE fell more than 72% at its lowest point during trading
